The Baldwin Insurance Group Inc. [BWIN] stock prices are up 0.84% to $33.68 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BWIN shares have gain 3.12% over the last week, with a monthly amount glided 26.38%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
The Baldwin Insurance Group Inc. [NASDAQ: BWIN] stock has seen the most recent analyst activity on April 08, 2024, when JP Morgan upgraded its rating to a Overweight and also boosted its price target to $33 from $27. Previously, Raymond James upgraded its rating to Strong Buy on December 12, 2023, and kept the price target unchanged to $30. On November 08, 2023, downgrade downgraded it’s rating to Equal Weight and revised its price target to $24 on the stock. William Blair downgraded its rating to a Mkt Perform. JP Morgan downgraded its rating to a Neutral and reduced its price target to $30 on October 03, 2022. UBS started tracking with a Buy rating for this stock on April 18, 2022, and assigned it a price target of $30. In a note dated March 14, 2022, BofA Securities upgraded an Buy rating on this stock but restated the target price of $31.
The stock price of The Baldwin Insurance Group Inc. [BWIN] has been fluctuating between $17.33 and $35.46 over the past year. The Baldwin Insurance Group Inc. [NASDAQ: BWIN] shares were valued at $33.68 at the most recent close of the market.
Analyzing the BWIN fundamentals
The The Baldwin Insurance Group Inc. [NASDAQ:BWIN] reported sales of 1.27B for trailing twelve months, representing a surge of 15.11%.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 33.15 points at the first support level, and at 32.62 for the second support level. However, for the 1st resistance point, the stock is sitting at 34.07, and for the 2nd resistance point, it is at 34.46.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 1.76, the price to book ratio is 3.67.
Transactions by insiders
Recent insider trading involved Baldwin Lowry, Director, that happened on May 21 ’24 when 0.12 million shares were sold., Roche James Morgan completed a deal on May 13 ’24 to sell 5000.0 shares. Meanwhile, Galbraith Daniel sold 80932.0 shares on May 10 ’24.
